
Breaking the Bottleneck: How Venetoclax Retreatment CLL Protocols Are Reshaping Blood Cancer Therapy
For patients with chronic lymphocytic leukaemia, relapse has historically presented a daunting hurdle. A new review of ten studies indicates that retreating patients with venetoclax is highly effective, offering a second chance at deep remission.










